Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Traffic. 2018 May 11;19(8):569–577. doi: 10.1111/tra.12573

Tying Trafficking to Fusion and Fission at the Mighty Mitochondria

Trey Farmer 1, Naava Naslavsky 1, Steve Caplan 1,2,*
PMCID: PMC6043374  NIHMSID: NIHMS960950  PMID: 29663589

Abstract

The mitochondrion is a unique organelle that serves as the main site of adenosine triphosphate (ATP) generation needed for energy in the cell. However, mitochondria also play essential roles in cell death through apoptosis and necrosis, as well as a variety of crucial functions related to stress regulation, autophagy, lipid synthesis, and calcium storage. There is a growing appreciation that mitochondrial function is regulated by the dynamics of its membrane fusion and fission; longer, fused mitochondria are optimal for ATP generation, whereas fission of mitochondria facilitates mitophagy and cell division. Despite the significance of mitochondrial homeostasis for such crucial cellular events, the intricate regulation of mitochondrial fusion and fission is only partially understood. Until very recently, only a single mitochondrial fission protein had been identified. Moreover, only now have researchers turned to address the upstream machinery that regulates mitochondrial fusion and fission proteins. Herein, we review the known GTPases involved in mitochondrial fusion and fission, but also highlight recent studies that address the mechanisms by which these GTPases are regulated. In particular, we draw attention to a substantial new body of literature linking endocytic regulatory proteins, such as the retromer VPS35 cargo selection complex subunit, to mitochondrial homeostasis. These recent studies suggest that relationships and cross-regulation between endocytic and mitochondrial pathways may be more widespread than previously assumed.

Keywords: mitochondria, homeostasis, fusion, fission, Optic atrophy protein 1 (OPA1), Mitofusin-1 (Mfn), Mitofusin-2, Dynamin-related protein-1 (Drp1), Dynamin2 (Dyn2/Dnm2), retromer, Vacuole protein sorting 35 (VPS35), Rabankyrin-5, Eps15 homology domain-containing protein 1 (EHD1)

Graphical Abstract

graphic file with name nihms960950u1.jpg

1. Introduction

Mitochondria are well-known for the generation of cellular ATP via oxidative phosphorylation, but also have a significant role in regulating a variety of key cellular events including reactive oxygen species generation and sequestration 1, calcium signaling 2,3, apoptosis 4, iron homeostasis 5,6, and cellular aging 7,8. Mitochondrial function is highly regulated by the dynamics of this unique organelle that continuously undergoes sequential rounds of fusion and fission, a process that is essential for not only the mitochondrial homeostasis and health, but also the well-being of the entire cell.

Given the major role that mitochondria play in a cell’s overall fitness, it is not surprising to find that mitochondrial dysfunction, caused by impairment of either the fusion or fission process, ultimately results in a variety of pathologies including neurodegenerative diseases, cardiovascular diseases, and metabolic diseases 9. Despite recent advances and the identification of new proteins involved in mitochondrial homeostasis, many questions concerning the mechanisms by which these molecules influence mitochondria remain unresolved. Here we examine the established proteins involved in the regulation of mitochondrial fusion and fission, and highlight the role of several proteins that were recently implicated in these processes. In particular, the retromer complex subunits and associated proteins are discussed, as well as new evidence detailing how they influence mitochondrial dynamics.

2. Mitochondrial homeostasis

Mitochondria are complex organelles that are encased by an outer mitochondrial membrane (OMM) and an inner mitochondrial membrane (IMM), which generates two compartments: the intermembrane space and the matrix. Under physiological conditions, the two membranes must constantly work in tandem and cooperate in serial rounds of fusion and fission, leading to a dynamic homeostatic system within the cell 10. This is especially important because mitochondrial morphology has physiological significance; mitochondrial function depends on the dynamic nature and continuous yin-yang relationship between fusion and fission.

Although both fusion and fission are crucial to homeostasis and mitochondrial function, each process serves different roles in controlling mitochondrial function. Mitochondrial fusion, which results in the elongation of mitochondrial structures, leads to an increase in ATP production, and the transfer of mitochondrial material, such as various metabolites, to newly fused mitochondria 11,12. Fusion events may be especially important under stress and starvation conditions, where maximizing ATP production is crucial for survival 13. In comparison, mitochondrial fission allows for the generation of new, smaller mitochondria, which are easier to distribute between dividing cells during mitosis 14. Not only does fission produce mitochondria that are more mobile, it also generates mitochondria that are able to undergo mitophagy, which is key to mitochondrial turnover 15,16.

Mitochondrial biogenesis and mitophagy, as controlled by fusion or fission, respectively, are highly regulated processes and highlight the dramatic influence that mitochondrial homeostasis has on the cell. Under normal circumstances, fusion and fission occur simultaneously and at approximately the same rate; accordingly, any change in the homeostatic balance due to cellular stimuli may result in elongated or fragmented mitochondria. The physiological significance of mitochondrial fusion and/or fission dysfunction is illustrated by the growing number of pathological conditions related directly to mitochondrial homeostasis (Table 1) 17,18.

Table 1.

Partial list of common mitochondrial-associated diseases related to fusion or fission.

Disorder Characteristics Altered Proteins or Genes Mitochondrial Impact
Alzheimer’s Disease Neuronal death in cerebral cortex APP, Presenilin Decrease in fusion and increase in fission 43,90,91
Parkinson’s Disease Degeneration of dopaminergic neurons Pink1, DJ-1, Parkin, VPS35 Enhanced mitochondrial fission, decrease in electron transport chain, increase in oxidative stress, decrease in mitophagy 64,92,93
Charcot-Marie-Tooth type 2A Affects distal extremity sensory and motor neurons Mfn2 Decrease in fusion 9496
Autosomal dominant optic atrophy Degeneration of retinal ganglia cells OPA1 Decrease in fusion 33,97,98
Cardiomyocyte hypertrophy Abnormal enlargement or thickening of the heart muscle Drp1 Increase in fission 44,45,99
Type-2 Diabetes Improper use of insulin that results in high blood glucose levels Mfn2, ATP synthase Decrease in fusion and decrease in ATP production 100103

2.1 Role of mitochondrial homeostasis in disease

Mitochondrial disorders consist of a diverse group of diseases that are associated with mitochondrial dysfunction. Since mitochondria are semi-autonomous, they are comprised of proteins encoded by mitochondrial DNA (mtDNA), as well as proteins that are encoded by nuclear DNA (nDNA), and mutations in either set of genes may result in dysfunctional mitochondria. Indeed, mitochondria play vital functions in all nucleated cells, many of which are impacted by gene mutations in the form of primary or secondary mitochondrial-related diseases.

Primary mitochondrial diseases (PMD) are diseases that cause either complete or partial dysfunction of the mitochondrial electron transport chain due to mutations in mtDNA or nDNA that impair the biogenesis of proteins that facilitate oxidative phosphorylation 19. Secondary mitochondrial diseases (SMD) are illnesses in which there is a mitochondrial phenotype without identifiable mtDNA or nDNA mutations, or there are identifiable mutations whose clinical significance remains unknown 19. Moreover, by definition, SMD are caused by genes that influence environmental factors, and do not encode for proteins involved in production or regulation of oxidative phosphorylation 19.

Whether a mitochondrial disease primarily affects a specific organ(s) or body system varies with the given illness, but in most cases, the disease impacts cells/tissues/organs that require high levels of energy production and consumption, such as neuronal tissues, muscles, and the heart 20. Just as there is wide variance in the range of tissues affected by mitochondrial diseases, the symptoms these diseases present with are broad and include neuropathies, myopathies, and cardiovascular disorders. Examples of some of the more common mitochondria-related diseases, their characteristics, the affected molecules, as well as the impact on mitochondria, are listed in Table 1. Many of these diseases result from a lack of balanced fission and fusion, resulting in mitochondria that are either dysfunctional or severely impaired. Although alterations in mitochondrial function are recognized as secondary contributors to the disease state, recent studies demonstrate that the implications of such dysfunction are crucial for disease progression 21. Despite a recent surge in the research of diseases associated with mitochondrial dysfunction, key mechanistic aspects underlying the physiology of impaired mitochondrial function remain poorly understood, highlighting the need for further research to support the development of novel therapeutics.

3. Direct Players in Mitochondrial Fusion and Fission

3.1 Effectors of Fusion

For two mitochondria to fuse together, two distinct fusion events need to occur between opposing mitochondria: 1) fusion between the OMM, and 2) fusion between the IMM. To date, three known mammalian GTPases have been associated with the process of mitochondrial fusion. Mitofusin-1 (Mfn1) and Mitofusin-2 (Mfn2) control fusion of the OMM, while the IMM is fused together by Optic Atrophy 1 (OPA1). The process of mitochondrial fusion is crucial for mitochondrial health, and blocked fusion results in a lack of membrane potential, and ultimately, impaired production of ATP 22. Fusion is also vital for the successful transfer of mitochondrial proteins and mtDNA to newly synthesized mitochondria, which helps prevent accumulation of mtDNA mutations and promotes normal mitochondrial function 23.

3.1.1. Mitofusin-1 and Mitofusin-2

Mfn1 and Mfn2 serve similar functions, as both are responsible for the fusion of the OMM (Fig. 1), and are even interchangeable 22. Strikingly, despite their similarity and overlapping functions, and even though Mfn1 and Mfn2 are able to replace one another under certain circumstances, mutations in Mfn2 alone have significant physiological consequences and can result in neurodegenerative diseases such as Charcot-Marie-Tooth Neuropathy type 2A (Table 1) 11,22. This suggests that cellular function is acutely attuned to OMM fusion, and that even minor disturbances in mitochondrial homeostasis can lead to significantly impaired mitochondrial function and disease. However, given the role of Mfn2 as an endoplasmic reticulum (ER)-mitochondrial tether 24, Charcot-Marie-Tooth Neuropathy type 2A disease could potentially result from interference with ER-mitochondrial cross-talk.

Figure 1. Mitochondrial Fusion.

Figure 1

Mitochondria fusion via homotypic and heterotypic mitofusin interactions mediates OMM fusion, while OPA1 is responsible for IMM fusion events.

Mfn1 and Mfn2 are OMM transmembrane GTPases that contain several conserved domains, such as an amino-terminal GTP-binding domain, two coiled-coil domains, and a carboxyl-terminal with a bipartite transmembrane domain 25. The difference between the Mfn1 and Mfn2 is that Mfn2 has an N-terminal Ras-binding domain that is lacking in Mfn1, suggesting that Mfn2 may have specific cellular functions that are not shared with Mfn1 26. The second coiled-coil domain of each protein is responsible for the tethering of the opposing mitochondria through a dimeric anti-parallel coiled-coil structure forming either homotypic or heterotypic dimers 27. The precise mechanism by which mitofusin proteins promote fusion by dimerization of molecules on adjacent mitochondria is currently an active area of research.

3.1.2. Optic atrophy protein 1 (OPA1)

The major protein responsible for fusion of the IMM is OPA1 (Fig. 1). OPA1 has also been associated with functions such as cristae folding and apoptosis 28,29. Whereas OPA1 function requires the presence of Mfn1, surprisingly Mfn2 is superfluous 30. OPA1 is crucial for overall mitochondrial function, and its mutations can lead to Dominant Atrophy (DOA), an inherited disorder leading to optic nerve degeneration and the most common disease related to OPA1 31,32. Additional disorders caused by OPA1 mutations include ataxia, sensorineural deafness, and mitochondrial myopathy 3335.

For OPA1 to become activated once it has been transported to mitochondria, it must undergo proteolytic cleavage into two isoforms, known as the long and short forms 36. The relative concentrations of the two isoforms under normal physiological conditions are nearly equal and are considered essential for proper OPA1 function in IMM fusion 37. The long and short isoforms do not have any fusion function separately but must work in tandem to successfully mediate the fusion of the IMM 38.

3.2 Effectors of Fission

Just as important as the mediators of mitochondrial fusion for homeostasis are the proteins that are responsible for mitochondrial membrane fission activity. Mitochondria are continuously executing a careful balancing act that, in addition to fusion, requires constant regulated division, termed mitochondrial fission. A long-acknowledged key player of mitochondrial fission is the GTPase, dynamin-related protein 1 (Drp1) 39. However, more recently, researchers have discovered that an additional GTPase protein, dynamin-2 (Dyn2/Dnm2), directly coordinates mitochondrial fission with Drp1 40. While the GTPases are thought to provide the energy for fission from GTP hydrolysis, the process of fission requires a broader and more elaborate platform that involves other organelles such as the endoplasmic reticulum (ER), which helps initiate mitochondrial constriction prior to GTPase function. Fission events are crucial for mitochondrial remodeling and rearrangement within the cell or for their transfer to daughter cells following mitosis 41. Due to the importance of such events, subtle changes in the rate of mitochondrial fission can influence disease states such as Alzheimer’s disease 42,43 and cardiomyocyte hypertrophy 44,45.

3.2.1. ER/mitochondria contact sites

Contact sites exist between the ER and the mitochondria (Fig. 2) and studies have shown that these sites are crucial for phospholipid synthesis, calcium signaling, as well as for mitochondrial constriction to mark fission sites 46,47. Indeed, there are several types of bridges that connect these two distinct organelles. For example, in yeast, a distinct structure termed the ER Mitochondria Encounter Structure (ERMES) is involved in mitochondrial fission, and in mammalian cells, Mfn2 is potentially responsible for such contact sites 48,49. A more recent study has identified PDZD8, a structural and functional homolog of the yeast ERMES protein MMM1, as playing a key role in tethering mitochondria to the ER in mammalian neurons 50. Even though mitochondria are exceptionally dynamic in nature, the contact sites between the mitochondria and ER seem to remain relatively stable, underscoring their physiological significance 51.

Figure 2. Mitochondrial Fission.

Figure 2

Constriction of the mitochondrial membrane is first initiated by the ER at ER/mitochondria contact sites. After constriction by the ER, the mitochondrial membrane is “marked” for fission, thus resulting in Drp1 recruitment by Drp1 receptors. Drp1 then forms oligomers around the constriction site and further constricts the membrane through GTPase activity, leading to Dyn2/Dnm2 recruitment, additional GTP hydrolysis, and completion of the process of fission resulting in two separate mitochondria.

It has been proposed that the role of the ER is to mark the initial site for mitochondrial constriction and fission 47,52. Indeed, Korobova et al. demonstrate that the ER-localized inverted formin 2 (INF2) induces actin polymerization between ER and mitochondrial contact sites, which drives initial constriction of mitochondrial fission sites 52. This is essential, because Drp1 oligomers are unable to wrap around the mitochondrial membrane and induce fission without initial constriction from another source. Mitochondria have a diameter of ~200 nm or more, depending on the cell type, while Drp1 oligomers sense and bind to mitochondrial membranes with a diameter of ~110–130 nm, before further constricting the membrane 47. In line with this, it has been observed that ER-constricted sites have a diameter of ~138–146 nm, suggesting that ER-initiated constriction is an essential prelude to the formation of Drp1 oligomers at mitochondrial membrane constriction sites 47.

3.2.2. Drp1

Drp1 is mainly localized to the cytoplasm, meaning that it must be recruited to mitochondria to complete mitochondrial fission. Unlike its family member and related protein, Dyn2/Dnm2, Drp1 does not possess a lipid-binding pleckstrin homology domain, and is unable to bind directly to the mitochondrial membrane 41,53. Accordingly, mitochondrial resident proteins must act as binding sites or receptors for Drp1 at the constriction sites (Fig. 2). In mammalian cells, many Drp1 receptors on mitochondria have been identified, including mitochondrial fission 1 protein (Fis1), mitochondrial fission factor (Mff), and mitochondrial dynamics protein of 49 kDa and 51 kDa (MiD49/MiD51) 5458. Studies have found that Fis1 localizes indiscriminately along the mitochondrial membrane, while Mff and the MiD proteins have a more restricted localization to punctae along the mitochondrial membrane. Although all the Drp1 receptors are able to recruit Drp1 to the outer mitochondrial membrane, evidence suggests that Mff has the more predominant role 54. Once recruited to the mitochondrial membrane, Drp1 forms a circular oligomer that uses its GTPase activity to further constrict the mitochondria, but does not complete the fission process due to constriction limits 59 (Fig. 2).

3.2.3. Dyn2/Dnm2

Dyn2/Dnm2has been well-established as the major membrane pinching and fission protein at the neck of budding clathrin-coated vesicles at the plasma membrane 60. Similar to Drp1, Dyn2/Dnm2molecules form a circular oligomer around the membrane and following GTP hydrolysis, fission is completed 61. Until recently, it was thought that after the initial mitochondrial constriction generated by the ER, Drp1 would further constrict the mitochondria until a single mitochondria split into two separate membranes, completing a fission event. New evidence now demonstrates that Dyn2/Dnm2 not only acts at the plasma membrane, but also has a vital role in the advanced stages of mitochondrial fission, following initial constriction by the ER and Drp1 40. The crucial role of both GTPase proteins in mitochondrial fission is demonstrated by experiments showing that if either protein is depleted, the mitochondria become elongated and display a more elaborate tubular network 40. Such experiments by Lee et al. further highlight the growing appreciation of previously uncharacterized links between endocytic pathways and mitochondria 40.

4. Expanding the regulation of Mitochondrial Fusion and Fission

Traditionally, mitochondrial homeostasis was relegated to the regulation of the GTPase proteins, Mfn1/2, OPA1, Drp1, their mitochondrial outer membrane receptors, and more recently, Dyn2/Dnm2. Perhaps surprisingly, only very recently has the vast complexity of mitochondria homeostasis regulation been revealed as far more intricate than previously imagined. Upstream events associated with the trafficking and regulation of the known regulatory proteins are essential for the regulation of the fusion/fission GTPase proteins, thus providing a mechanism for indirectly regulating the rates of mitochondrial fusion and fission. In addition, many of the new indirect mitochondrial regulatory proteins have also been implicated in mitochondrial-related diseases (Table 1).

One key protein that indirectly regulates mitochondrial homeostasis through the trafficking of various mitochondrial proteins is vacuolar protein sorting-35 (VPS35) 6264. VPS35 is a subunit of the retromer cargo selective complex (CSC). The retromer CSC is comprised of three main vacuolar protein sorting proteins termed, VPS26, VPS29, and VPS35, and is usually affiliated with one or more sorting nexin proteins 65. The original function ascribed to the mammalian retromer complex was to retrieve mannose 6-phosphate receptor from peripheral endosomes to the Golgi complex 66. In addition to the mannose 6-phosphate receptor, other identified cargo include the iron transporter DMT1-11/Slc11a2 67, the Wnt transport protein Wntless/MIG-14 68, and others. Exciting new studies implicate VPS35 and the retromer complex in PD and the regulation of mitochondrial fusion and fission, establishing a novel connection between an endocytic trafficking complex and the mitochondrion, a non-endocytic organelle. However, while VPS35 has a definite relationship with mitochondrial dynamics and PD, the mechanism(s) by which VPS35 regulates mitochondrial morphology remains somewhat controversial.

4.1. Indirect Role of VPS35 in Mitochondrial Fusion

Proteins associated with the fusion of mitochondrial membranes may be regulated by post-translational modifications, with one key modification being ubiquitination. The ubiquitination of mitochondrial-membrane-associated Mfn2 targets this fusion protein for proteasomal degradation, thus limiting mitochondrial fusion. A recent study has demonstrated that VPS35 affects this mechanism of Mfn2 regulation, most likely by controlling the trafficking of the E3 ubiquitin ligase, MUL1, to the mitochondrial membrane 64. Tang et al. have shown that VPS35-depletion in mouse dopamine neurons induces a PD-like condition, which presents with α-synuclein deposition, fragmented mitochondria and cell death 64. In this scenario, VPS35 interacts with MUL1 and sequesters it in the cytoplasm; the release of MUL1 from this interaction is thought to facilitate its transport to the mitochondrial membrane, where it ubiquitinates Mfn2 and induces the latter’s proteasomal degradation 64 (Fig. 3). Upon VPS35 dysfunction, MUL1 is more freely available at the mitochondrial membrane, leading to enhanced Mfn2 degradation, fewer fusion events, and thus fragmented mitochondrial morphology.

Fig. 3. Potential roles of VPS35 in mitochondrial fission/fusion.

Fig. 3

Model representing the role of VPS35 (pink) in mitochondrial fission (bottom left) or mitochondrial fusion (top right). For fission, VPS35 removes inactive Drp1 (red) and traffics it to the lysosome for degradation, to allow active Drp1 (green) to further constrict the OMM. For fusion, VPS35 regulates MUL1 (orange) localization to the OMM, where it binds to Mfn2 (red) and induces its polyubiquitination (yellow) to target it for proteasomal degradation.

4.2.1. Indirect role of VPS35 in Mitochondrial Fission

While VPS35 may regulate mitochondrial fusion by its control of MUL1, a recent study provides evidence for a different model for VPS35 function in the regulation of mitochondrial fission. Wang et al. demonstrated that VPS35 binds to complexes of Drp1 on the mitochondrial membrane that are considered inactive. By binding to these complexes on the mitochondrial membrane, vesicles containing VPS35 (and perhaps the entire retromer CSC) are proposed to promote the generation of mitochondrial-derived vesicles (MDVs) and remove the inactive Drp1 for transport to lysosomes for degradation 62,63 (Fig. 3). Subsequently, this frees up constriction sites for the recruitment and/or activation of Drp1 and promotes mitochondrial fission and fragmentation 62,63. MDVs are defined as structures with diameters of 70–150 nm 69, and are considered quality control mechanisms for mitochondria that deliver mitochondria-related contents to the late endosome or multivesicular bodies 70. Although the exact mechanism of incorporation of the selected cargo is unclear, studies have shown that both the outer and inner membranes can be used to form MDVs, carrying membrane bound or mitochondrial matrix proteins 7074. It is noteworthy that a mutated form of VPS35 commonly found in PD, VPS35D620N, causes extensive mitochondrial fragmentation and loss of function, providing additional insight to the mechanism by which VPS35 affects PD.

4.2.2. Indirect Role of Retromer-Associated Proteins: EHD1 and Rabankyrin-5

Given the crucial role of VPS35 in mitochondrial homeostasis and related diseases, it would not be surprising to find that retromer CSC, accessory proteins, or interaction partners might also influence mitochondrial fusion and fission. For example, several VPS26A mutations have been implicated in atypical PD 75,76. Moreover, a recent study has demonstrated that extended/accessory members of the retromer complex, including the Eps15 homology domain protein 1 (EHD1), and its interaction partner, Rabankyrin-5, also influence mitochondrial homeostasis 77. EHD1, an ATPase with homology to the dynamin family of GTPases, has a well-established role in regulating recycling from the endocytic recycling compartment to the plasma membrane, and likely functions in the fission of tubules and vesicles from endosomes 7880. Recent studies have demonstrated a link between EHD1 and the retromer 81, although apparently independent of Rabankyrin-5 81,82, suggesting that EHD1 and Rabankyrin-5 somehow function upstream of the mitochondrial fission and fusion proteins.

As predicted, both EHD1 and Rabankyrin-5 affect mitochondrial homeostasis and dynamics 77. Upon either EHD1- or Rabankyrin-5-depletion, mitochondria become highly static and elongated in nature, reminiscent of Drp1-depletion. Although an interaction was observed between EHD1 and MUL1, the ubiquitin ligase responsible for regulating Mfn2, the latter’s expression levels failed to increase as anticipated if less proteasomal degradation of Mfn2 was occurring upon EHD1-depletion 77. Accordingly, EHD1 and Rabankyrin-5 most likely regulate VPS35 expression and/or its subcellular distribution, potentially controlling the level of active Drp1 at mitochondrial constriction sites.

The regulation of both retromer and mitochondrial homeostasis by EHD1 and Rabankyrin-5, both interactors and/or effectors of small Rab GTP-binding proteins, suggests that the Rab-family of proteins may also bear impact on mitochondrial function. Although links between Rab proteins and mitochondrial homeostasis remain elusive, a large body of literature does support the involvement of many different Rab GTP-binding proteins in PD (reviewed in 83). At least one Rab protein, Rab32, localizes to the mitochondrial membrane and interacts with the PD-related protein, Leucine-rich repeat kinase 2 (LRRK2) 84. Strikingly, Rab7, which also functionally interacts with LRRK2 85 has also been implicated in recruitment of the retromer CSC to the endosomal membrane 86. Thus, it would be tempting to speculate that Rab7 might influence PD not only through its relationship with LRRK2, but also by its regulation of the retromer, and subsequently, mitochondrial homeostasis.

5. Future Perspectives

Growing recognition of the relationships between endocytic regulatory proteins and mitochondria has shed light on novel mechanisms involved in mitochondrial homeostasis. In addition to the bifunctional role for the GTPase Dyn2/Dnm2 in both endocytic fission at the plasma membrane and in mitochondrial fission, the involvement of the retromer and its interaction proteins in mitochondrial homeostasis has further solidified the links between endocytic pathways and mitochondria. It remains to be determined whether additional endocytic regulatory complexes that function in coordination with the retromer, including the WASH complex 87, the newly-discovered retriever complex 88, and the Command (CCC) complex 89 might also influence mitochondrial homeostasis. Moreover, whether mitochondrial fusion and fission proteins play any role in endocytic regulation remains entirely unknown.

SYNOPSIS.

The mitochondrion is the major energy producing cellular organelle. There is a growing appreciation that mitochondrial function is regulated by the dynamics of its membrane fusion and fission. Herein, we review the known GTPases involved in mitochondrial fusion and fission, and highlight recent studies addressing their mechanisms of regulation. In particular, we review the involvement of the retromer complex in mitochondrial homeostasis, and we speculate that cross-regulation between endocytic and mitochondrial pathways may be more widespread than previously assumed.

Acknowledgments

The authors gratefully acknowledge funding support from NIH grant 1R01GM123557-01A1 (SC) from the National Institutes of General Medical Sciences. The authors declare that they have no conflicts of interest.

References

  • 1.Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci. 2010;35(9):505–513. doi: 10.1016/j.tibs.2010.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol. 2000;529(Pt 1):57–68. doi: 10.1111/j.1469-7793.2000.00057.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nicholls DG. Mitochondria and calcium signaling. Cell Calcium. 2005;38(3–4):311–317. doi: 10.1016/j.ceca.2005.06.011. [DOI] [PubMed] [Google Scholar]
  • 4.Wang C, Youle RJ. The role of mitochondria in apoptosis*. Annu Rev Genet. 2009;43:95–118. doi: 10.1146/annurev-genet-102108-134850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Horowitz MP, Greenamyre JT. Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis. 2010;20(Suppl 2):S551–568. doi: 10.3233/JAD-2010-100354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Richardson DR, Lane DJ, Becker EM, et al. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A. 2010;107(24):10775–10782. doi: 10.1073/pnas.0912925107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Srivastava S. The Mitochondrial Basis of Aging and Age-Related Disorders. Genes (Basel) 2017;8(12) doi: 10.3390/genes8120398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sun N, Youle RJ, Finkel T. The Mitochondrial Basis of Aging. Mol Cell. 2016;61(5):654–666. doi: 10.1016/j.molcel.2016.01.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Archer SL. Mitochondrial dynamics--mitochondrial fission and fusion in human diseases. N Engl J Med. 2013;369(23):2236–2251. doi: 10.1056/NEJMra1215233. [DOI] [PubMed] [Google Scholar]
  • 10.Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev. 2008;22(12):1577–1590. doi: 10.1101/gad.1658508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005;280(28):26185–26192. doi: 10.1074/jbc.M503062200. [DOI] [PubMed] [Google Scholar]
  • 12.Yang WY. Optogenetic probing of mitochondrial damage responses. Ann N Y Acad Sci. 2015;1350:48–51. doi: 10.1111/nyas.12818. [DOI] [PubMed] [Google Scholar]
  • 13.Silva Ramos E, Larsson NG, Mourier A. Bioenergetic roles of mitochondrial fusion. Biochim Biophys Acta. 2016;1857(8):1277–1283. doi: 10.1016/j.bbabio.2016.04.002. [DOI] [PubMed] [Google Scholar]
  • 14.Horbay R, Bilyy R. Mitochondrial dynamics during cell cycling. Apoptosis. 2016;21(12):1327–1335. doi: 10.1007/s10495-016-1295-5. [DOI] [PubMed] [Google Scholar]
  • 15.Twig G, Elorza A, Molina AJ, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008;27(2):433–446. doi: 10.1038/sj.emboj.7601963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy. 2009;5(5):706–708. doi: 10.4161/auto.5.5.8505. [DOI] [PubMed] [Google Scholar]
  • 17.Duchen MR. Roles of mitochondria in health and disease. Diabetes. 2004;53(Suppl 1):S96–102. doi: 10.2337/diabetes.53.2007.s96. [DOI] [PubMed] [Google Scholar]
  • 18.Suarez-Rivero JM, Villanueva-Paz M, de la Cruz-Ojeda P, et al. Mitochondrial Dynamics in Mitochondrial Diseases. Diseases. 2016;5(1) doi: 10.3390/diseases5010001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Niyazov DM, Kahler SG, Frye RE. Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment. Mol Syndromol. 2016;7(3):122–137. doi: 10.1159/000446586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283(5407):1482–1488. doi: 10.1126/science.283.5407.1482. [DOI] [PubMed] [Google Scholar]
  • 21.Murphy E, Ardehali H, Balaban RS, et al. Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association. Circ Res. 2016;118(12):1960–1991. doi: 10.1161/RES.0000000000000104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol. 2003;160(2):189–200. doi: 10.1083/jcb.200211046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Twig G, Shirihai OS. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal. 2011;14(10):1939–1951. doi: 10.1089/ars.2010.3779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Naon D, Zaninello M, Giacomello M, et al. Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum-mitochondria tether. Proc Natl Acad Sci U S A. 2016;113(40):11249–11254. doi: 10.1073/pnas.1606786113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chandhok G, Lazarou M, Neumann B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol Rev Camb Philos Soc. 2017 doi: 10.1111/brv.12378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chen KH, Guo X, Ma D, et al. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 2004;6(9):872–883. doi: 10.1038/ncb1161. [DOI] [PubMed] [Google Scholar]
  • 27.Koshiba T, Detmer SA, Kaiser JT, Chen H, McCaffery JM, Chan DC. Structural basis of mitochondrial tethering by mitofusin complexes. Science. 2004;305(5685):858–862. doi: 10.1126/science.1099793. [DOI] [PubMed] [Google Scholar]
  • 28.Ni HM, Williams JA, Ding WX. Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 2015;4:6–13. doi: 10.1016/j.redox.2014.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Griparic L, van der Wel NN, Orozco IJ, Peters PJ, van der Bliek AM. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem. 2004;279(18):18792–18798. doi: 10.1074/jbc.M400920200. [DOI] [PubMed] [Google Scholar]
  • 30.Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci U S A. 2004;101(45):15927–15932. doi: 10.1073/pnas.0407043101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chen H, Chan DC. Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet. 2005;14(2):R283–289. doi: 10.1093/hmg/ddi270. [DOI] [PubMed] [Google Scholar]
  • 32.Chen H, Chan DC. Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet. 2009;18(R2):R169–176. doi: 10.1093/hmg/ddp326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26(2):211–215. doi: 10.1038/79944. [DOI] [PubMed] [Google Scholar]
  • 34.Amati-Bonneau P, Odent S, Derrien C, et al. The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene. Am J Ophthalmol. 2003;136(6):1170–1171. doi: 10.1016/s0002-9394(03)00665-2. [DOI] [PubMed] [Google Scholar]
  • 35.Li C, Kosmorsky G, Zhang K, Katz BJ, Ge J, Traboulsi EI. Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation. Am J Med Genet A. 2005;138A(3):208–211. doi: 10.1002/ajmg.a.30794. [DOI] [PubMed] [Google Scholar]
  • 36.Ishihara N, Fujita Y, Oka T, Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006;25(13):2966–2977. doi: 10.1038/sj.emboj.7601184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Liesa M, Palacin M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev. 2009;89(3):799–845. doi: 10.1152/physrev.00030.2008. [DOI] [PubMed] [Google Scholar]
  • 38.Song Z, Chen H, Fiket M, Alexander C, Chan DC. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol. 2007;178(5):749–755. doi: 10.1083/jcb.200704110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Smirnova E, Griparic L, Shurland DL, van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell. 2001;12(8):2245–2256. doi: 10.1091/mbc.12.8.2245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lee JE, Westrate LM, Wu H, Page C, Voeltz GK. Multiple dynamin family members collaborate to drive mitochondrial division. Nature. 2016;540(7631):139–143. doi: 10.1038/nature20555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Pagliuso A, Cossart P, Stavru F. The ever-growing complexity of the mitochondrial fission machinery. Cell Mol Life Sci. 2018;75(3):355–374. doi: 10.1007/s00018-017-2603-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Castellani R, Hirai K, Aliev G, et al. Role of mitochondrial dysfunction in Alzheimer’s disease. J Neurosci Res. 2002;70(3):357–360. doi: 10.1002/jnr.10389. [DOI] [PubMed] [Google Scholar]
  • 43.Moreira PI, Cardoso SM, Santos MS, Oliveira CR. The key role of mitochondria in Alzheimer’s disease. J Alzheimers Dis. 2006;9(2):101–110. doi: 10.3233/jad-2006-9202. [DOI] [PubMed] [Google Scholar]
  • 44.Pennanen C, Parra V, Lopez-Crisosto C, et al. Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway. J Cell Sci. 2014;127(Pt 12):2659–2671. doi: 10.1242/jcs.139394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010;106(7):1253–1264. doi: 10.1161/CIRCRESAHA.109.213116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.de Brito OM, Scorrano L. An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J. 2010;29(16):2715–2723. doi: 10.1038/emboj.2010.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J, Voeltz GK. ER tubules mark sites of mitochondrial division. Science. 2011;334(6054):358–362. doi: 10.1126/science.1207385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kornmann B, Currie E, Collins SR, et al. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science. 2009;325(5939):477–481. doi: 10.1126/science.1175088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.de Brito OM, Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature. 2008;456(7222):605–610. doi: 10.1038/nature07534. [DOI] [PubMed] [Google Scholar]
  • 50.Hirabayashi Y, Kwon SK, Paek H, et al. ER-mitochondria tethering by PDZD8 regulates Ca(2+) dynamics in mammalian neurons. Science. 2017;358(6363):623–630. doi: 10.1126/science.aan6009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Friedman JR, Webster BM, Mastronarde DN, Verhey KJ, Voeltz GK. ER sliding dynamics and ER-mitochondrial contacts occur on acetylated microtubules. J Cell Biol. 2010;190(3):363–375. doi: 10.1083/jcb.200911024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Korobova F, Ramabhadran V, Higgs HN. An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. Science. 2013;339(6118):464–467. doi: 10.1126/science.1228360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Mears JA, Lackner LL, Fang S, Ingerman E, Nunnari J, Hinshaw JE. Conformational changes in Dnm1 support a contractile mechanism for mitochondrial fission. Nat Struct Mol Biol. 2011;18(1):20–26. doi: 10.1038/nsmb.1949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Loson OC, Song Z, Chen H, Chan DC. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24(5):659–667. doi: 10.1091/mbc.E12-10-0721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Otera H, Wang C, Cleland MM, et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol. 2010;191(6):1141–1158. doi: 10.1083/jcb.201007152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Palmer CS, Osellame LD, Laine D, Koutsopoulos OS, Frazier AE, Ryan MT. MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep. 2011;12(6):565–573. doi: 10.1038/embor.2011.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Palmer CS, Elgass KD, Parton RG, Osellame LD, Stojanovski D, Ryan MT. Adaptor proteins MiD49 and MiD51 can act independently of Mff and Fis1 in Drp1 recruitment and are specific for mitochondrial fission. J Biol Chem. 2013;288(38):27584–27593. doi: 10.1074/jbc.M113.479873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Zhao J, Liu T, Jin S, et al. Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J. 2011;30(14):2762–2778. doi: 10.1038/emboj.2011.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Frohlich C, Grabiger S, Schwefel D, et al. Structural insights into oligomerization and mitochondrial remodelling of dynamin 1-like protein. EMBO J. 2013;32(9):1280–1292. doi: 10.1038/emboj.2013.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Gonzalez-Jamett AM, Momboisse F, Haro-Acuna V, Bevilacqua JA, Caviedes P, Cardenas AM. Dynamin-2 function and dysfunction along the secretory pathway. Front Endocrinol (Lausanne) 2013;4:126. doi: 10.3389/fendo.2013.00126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol. 2012;13(2):75–88. doi: 10.1038/nrm3266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Wang W, Wang X, Fujioka H, et al. Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med. 2016;22(1):54–63. doi: 10.1038/nm.3983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Wang W, Ma X, Zhou L, Liu J, Zhu X. A conserved retromer sorting motif is essential for mitochondrial DLP1 recycling by VPS35 in Parkinson’s disease model. Hum Mol Genet. 2017;26(4):781–789. doi: 10.1093/hmg/ddw430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Tang FL, Liu W, Hu JX, et al. VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function. Cell Rep. 2015;12(10):1631–1643. doi: 10.1016/j.celrep.2015.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Seaman MN. Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol. 2004;165(1):111–122. doi: 10.1083/jcb.200312034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Arighi CN, Hartnell LM, Aguilar RC, Haft CR, Bonifacino JS. Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor. J Cell Biol. 2004;165(1):123–133. doi: 10.1083/jcb.200312055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Tabuchi M, Yanatori I, Kawai Y, Kishi F. Retromer-mediated direct sorting is required for proper endosomal recycling of the mammalian iron transporter DMT1. J Cell Sci. 2010;123(Pt 5):756–766. doi: 10.1242/jcs.060574. [DOI] [PubMed] [Google Scholar]
  • 68.Eaton S. Retromer retrieves wntless. Dev Cell. 2008;14(1):4–6. doi: 10.1016/j.devcel.2007.12.014. [DOI] [PubMed] [Google Scholar]
  • 69.Cadete VJ, Deschenes S, Cuillerier A, et al. Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system. J Physiol. 2016;594(18):5343–5362. doi: 10.1113/JP272703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Soubannier V, McLelland GL, Zunino R, et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr Biol. 2012;22(2):135–141. doi: 10.1016/j.cub.2011.11.057. [DOI] [PubMed] [Google Scholar]
  • 71.Neuspiel M, Schauss AC, Braschi E, et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr Biol. 2008;18(2):102–108. doi: 10.1016/j.cub.2007.12.038. [DOI] [PubMed] [Google Scholar]
  • 72.Soubannier V, Rippstein P, Kaufman BA, Shoubridge EA, McBride HM. Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PLoS One. 2012;7(12):e52830. doi: 10.1371/journal.pone.0052830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.McLelland GL, Soubannier V, Chen CX, McBride HM, Fon EA. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 2014;33(4):282–295. doi: 10.1002/embj.201385902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Sugiura A, McLelland GL, Fon EA, McBride HM. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014;33(19):2142–2156. doi: 10.15252/embj.201488104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Shannon B, Soto-Ortolaza A, Rayaprolu S, et al. Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson’s disease. Neurobiol Aging. 2014;35(8):1958e1951–1952. doi: 10.1016/j.neurobiolaging.2014.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Gustavsson EK, Guella I, Trinh J, et al. Genetic variability of the retromer cargo recognition complex in parkinsonism. Mov Disord. 2015;30(4):580–584. doi: 10.1002/mds.26104. [DOI] [PubMed] [Google Scholar]
  • 77.Farmer T, Reinecke JB, Xie S, Bahl K, Naslavsky N, Caplan S. Control of mitochondrial homeostasis by endocytic regulatory proteins. J Cell Sci. 2017;130(14):2359–2370. doi: 10.1242/jcs.204537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Cai B, Caplan S, Naslavsky N. cPLA2alpha and EHD1 interact and regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-containing endosomes. Mol Biol Cell. 2012;23(10):1874–1888. doi: 10.1091/mbc.E11-10-0881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Cai B, Xie S, Caplan S, Naslavsky N. GRAF1 forms a complex with MICAL-L1 and EHD1 to cooperate in tubular recycling endosome vesiculation. Front Cell Dev Biol. 2014;2:22. doi: 10.3389/fcell.2014.00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Cai B, Giridharan SS, Zhang J, et al. Differential roles of C-terminal Eps15 homology domain proteins as vesiculators and tubulators of recycling endosomes. J Biol Chem. 2013;288(42):30172–30180. doi: 10.1074/jbc.M113.488627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Gokool S, Tattersall D, Seaman MN. EHD1 interacts with retromer to stabilize SNX1 tubules and facilitate endosome-to-Golgi retrieval. Traffic. 2007;8(12):1873–1886. doi: 10.1111/j.1600-0854.2007.00652.x. [DOI] [PubMed] [Google Scholar]
  • 82.Zhang J, Reiling C, Reinecke JB, et al. Rabankyrin-5 interacts with EHD1 and Vps26 to regulate endocytic trafficking and retromer function. Traffic. 2012;13(5):745–757. doi: 10.1111/j.1600-0854.2012.01334.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Shi MM, Shi CH, Xu YM. Rab GTPases: The Key Players in the Molecular Pathway of Parkinson’s Disease. Front Cell Neurosci. 2017;11:81. doi: 10.3389/fncel.2017.00081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Waschbusch D, Michels H, Strassheim S, et al. LRRK2 transport is regulated by its novel interacting partner Rab32. PLoS One. 2014;9(10):e111632. doi: 10.1371/journal.pone.0111632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Gomez-Suaga P, Rivero-Rios P, Fdez E, et al. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum Mol Genet. 2014;23(25):6779–6796. doi: 10.1093/hmg/ddu395. [DOI] [PubMed] [Google Scholar]
  • 86.Seaman MN, Harbour ME, Tattersall D, Read E, Bright N. Membrane recruitment of the cargo-selective retromer subcomplex is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5. J Cell Sci. 2009;122(Pt 14):2371–2382. doi: 10.1242/jcs.048686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Seaman MN, Gautreau A, Billadeau DD. Retromer-mediated endosomal protein sorting: all WASHed up! Trends Cell Biol. 2013;23(11):522–528. doi: 10.1016/j.tcb.2013.04.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.McNally KE, Faulkner R, Steinberg F, et al. Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling. Nat Cell Biol. 2017;19(10):1214–1225. doi: 10.1038/ncb3610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Phillips-Krawczak CA, Singla A, Starokadomskyy P, et al. COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A. Mol Biol Cell. 2015;26(1):91–103. doi: 10.1091/mbc.E14-06-1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Onyango IG, Dennis J, Khan SM. Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies. Aging Dis. 2016;7(2):201–214. doi: 10.14336/AD.2015.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J Neurochem. 2009;109(Suppl 1):153–159. doi: 10.1111/j.1471-4159.2009.05867.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–795. doi: 10.1038/nature05292. [DOI] [PubMed] [Google Scholar]
  • 93.Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol. 2004;56(3):336–341. doi: 10.1002/ana.20256. [DOI] [PubMed] [Google Scholar]
  • 94.Loiseau D, Chevrollier A, Verny C, et al. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol. 2007;61(4):315–323. doi: 10.1002/ana.21086. [DOI] [PubMed] [Google Scholar]
  • 95.Pich S, Bach D, Briones P, et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet. 2005;14(11):1405–1415. doi: 10.1093/hmg/ddi149. [DOI] [PubMed] [Google Scholar]
  • 96.Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36(5):449–451. doi: 10.1038/ng1341. [DOI] [PubMed] [Google Scholar]
  • 97.Davies VJ, Hollins AJ, Piechota MJ, et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet. 2007;16(11):1307–1318. doi: 10.1093/hmg/ddm079. [DOI] [PubMed] [Google Scholar]
  • 98.Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26(2):207–210. doi: 10.1038/79936. [DOI] [PubMed] [Google Scholar]
  • 99.Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2007;49(2):241–248. doi: 10.1161/01.HYP.0000254415.31362.a7. [DOI] [PubMed] [Google Scholar]
  • 100.Bach D, Pich S, Soriano FX, et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem. 2003;278(19):17190–17197. doi: 10.1074/jbc.M212754200. [DOI] [PubMed] [Google Scholar]
  • 101.Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51(10):2944–2950. doi: 10.2337/diabetes.51.10.2944. [DOI] [PubMed] [Google Scholar]
  • 102.Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384–387. doi: 10.1126/science.1104343. [DOI] [PubMed] [Google Scholar]
  • 103.Rovira-Llopis S, Banuls C, Diaz-Morales N, Hernandez-Mijares A, Rocha M, Victor VM. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications. Redox Biol. 2017;11:637–645. doi: 10.1016/j.redox.2017.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES